Tbo-filgrastim more cost-effective than filgrastim for stem cell mobilization, engraftment
Compared with filgrastim, tbo-filgrastim delivers similar efficacy and confers a cost-savings benefit for autologous peripheral blood progenitor cell (PBPC) mobilization and stem cell engraftment, results of a retrospective review have shown.
Tbo-filgrastim more cost-effective than filgrastim for stem cell mobilization, engraftment
21 Dec 2019